生物活性 | |||
---|---|---|---|
描述 | PCSK9-IN-10 is a potent and orally active PCSK9 inhibitor with an IC50 value of 6.4 µM. PCSK9-IN-10 enhances the expression of LDLR protein while reducing PCSK9 expression. PCSK9-IN-10 demonstrates efficacy in reducing the progression of atherosclerosis and holds promise for research on hyperlipidemia [1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.68mL 0.54mL 0.27mL |
13.39mL 2.68mL 1.34mL |
26.78mL 5.36mL 2.68mL |
参考文献 |
---|